Preoperative Nutritional Status and Postoperative Outcomes in Colorectal Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06016829 |
Recruitment Status :
Completed
First Posted : August 30, 2023
Last Update Posted : February 28, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Colorectal Cancer | Diagnostic Test: Nutrition Risk Screening 2002 (NRS-2002) Diagnostic Test: Global Leadership Initiative on Malnutrition (GLIM) Other: Measurement of body composition with computed tomography (CT) Diagnostic Test: Dietary inflammatory index (DII) Diagnostic Test: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC-QLQ-C30) Diagnostic Test: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Colorectal Cancer 29 (EORTC-QLQ-CR29) Diagnostic Test: Prognostic Nutritional Index (PNI) Diagnostic Test: Neutrophil-Lymphocyte Ratio (NLR) |
A questionnaire form containing general information, dietary habits, and food consumption records will be applied by the researcher in the preoperative period to the patients who volunteered to participate in the study. Body composition will be taken by bioelectrical impedance analysis method. Hand grip strength will be taken with a digital hand dynamometer. The nutritional status of patients will be assessed using the criteria of the Nutritional Risk Screening 2002 (NRS-2002) and the Global Leadership Initiative on Malnutrition (GLIM). For body composition analysis, computed tomography images, known as the gold standard, will be used in cancer patients. Computed tomography images of the patients will be obtained from hospital records at L3 lumbar vertebra level. The software program ImageJ developed by the US National Institute of Health will be used to calculate the visceral fat area (cm2), subcutaneous fat area (cm2), and skeletal muscle area (cm2) from the recorded images.
Preoperative biochemical parameters will be obtained from hospital records. The systemic inflammatory response will be determined by the Prognostic Nutritional Index, Neutrophil Lymphocyte Ratio, and Delta Neutrophil Index. The inflammatory load of the diet will be calculated using the Dietary Inflammatory Index. The quality of life of patients will be assessed using cancer-specific scales developed by the European Organisation for Research and Treatment of Cancer (EORTC) during the preoperative and postoperative periods. These scales are EORTC-QLQ-C30 for general quality of life and EORTC-QLQ-CR29 for colorectal cancer-specific quality of life.
Study Type : | Observational |
Actual Enrollment : | 121 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | The Effect of Preoperative Nutritional Status, Dietary Inflammatory Index and Systemic Inflammatory Response on Postoperative Outcomes in Colorectal Cancer. |
Actual Study Start Date : | July 25, 2021 |
Actual Primary Completion Date : | December 1, 2022 |
Actual Study Completion Date : | December 1, 2022 |
- Diagnostic Test: Nutrition Risk Screening 2002 (NRS-2002)
Nutritional status assessment tool
- Diagnostic Test: Global Leadership Initiative on Malnutrition (GLIM)
Nutritional status assessment tool
- Other: Measurement of body composition with computed tomography (CT)
The cross section of the third lumbar vertebrae in the CT scan images of the patients will be analyzed for assessment of body composition parameters including skeletal muscle area (SMA), visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT)
- Diagnostic Test: Dietary inflammatory index (DII)
The Dietary Inflammatory Index (DII) is a scoring algorithm that indicates the inflammatory potential of the diet.
- Diagnostic Test: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC-QLQ-C30)
Quality of life assessment tool
- Diagnostic Test: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Colorectal Cancer 29 (EORTC-QLQ-CR29)
Quality of life assessment tool
- Diagnostic Test: Prognostic Nutritional Index (PNI)
Prognostic Nutritional Index is diagnostic test based on serum albumin level and total lymphocyte count
- Diagnostic Test: Neutrophil-Lymphocyte Ratio (NLR)
The neutrophil-to-lymphocyte ratio (NLR) is calculated as the simple ratio between neutrophil and lymphocyte counts.
- Postoperative complications [ Time Frame: within 30 days after surgery ]Complications graded by Clavien-Dindo Complication Classification System
- Postoperative quality of life [ Time Frame: within 45 days after surgery ]Quality of life will be evaluated by European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC-QLQ-C30).All of the scales and single-item measures range in score from 0 to 100. A high scale score represents a higher response level.
- EORTC-QLQ-CR29 [ Time Frame: within 45 days after surgery ]European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Colorectal Cancer 29 (EORTC-QLQ-CR29) is a supplementary questionnaire module to be employed in conjunction with the Quality of Life Questionnaire Core 30 (QLQ-C30). All of the scales and single-item measures range in score from 0 to 100. A high score for the functional scale and functional single-items represents a high level of functioning, whereas a high score for the symptom scales and symptom single-items represents a high level of symptomatology or problem.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Having been diagnosed with colorectal cancer and having surgical treatment planned
- Being 18 years of age or older
Exclusion Criteria:
- Having received chemotherapy or radiotherapy
- Currently undergoing corticosteroid or hormone treatment.
- Presence of distant metastases.
- Presence of any malignancy other than colorectal cancer.
- Presence of autoimmune disease.
- Presence of ongoing infectious disease.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06016829
Turkey | |
Hacettepe University | |
Ankara, Turkey, 06100 | |
Ankara City Hospital Bilkent | |
Ankara, Turkey, 06800 |
Principal Investigator: | Tuba N Yildiz Kopuz | Hacettepe University | |
Principal Investigator: | Mehmet Fisunoglu | Hacettepe University |
Responsible Party: | Tuba Nur Yildiz Kopuz, Principal Investigator, Hacettepe University |
ClinicalTrials.gov Identifier: | NCT06016829 |
Other Study ID Numbers: |
GO 21/499 |
First Posted: | August 30, 2023 Key Record Dates |
Last Update Posted: | February 28, 2024 |
Last Verified: | February 2024 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
colorectal cancer nutritional status body composition quality of life postoperative complication |
Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |